Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cadranel

Showing results (641-650 of 709) with videos related to

Pageof 71
Sort By:
Helicobacter|February 21, 2007
Results from the pediatric European register for treatment of Helicobacter pylori (PERTH)Giuseppina Oderda, Peter Shcherbakov, Patrick Bontems, et al.
European Journal of Gastroenterology & Hepatology|July 17, 2010
Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter studyNicolas Kalach, Patrick Bontems, Sibylle Koletzko, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2007
Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis--results of a nationwide surveyJ-F Cadranel, P Lahmek, X Causse, et al.
The European Respiratory Journal|August 5, 2017
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater ParisBoris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohortSimon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2008
Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional studyJean-François Cadranel, Vincent Di Martino, Guy Lambrey, et al.
Pageof 71

Showing results (641-650 of 709) with videos related to

Sort By:
Pageof 71
Helicobacter|February 21, 2007
Results from the pediatric European register for treatment of Helicobacter pylori (PERTH)Giuseppina Oderda, Peter Shcherbakov, Patrick Bontems, et al.
European Journal of Gastroenterology & Hepatology|July 17, 2010
Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter studyNicolas Kalach, Patrick Bontems, Sibylle Koletzko, et al.
Alimentary Pharmacology & Therapeutics|July 31, 2007
Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis--results of a nationwide surveyJ-F Cadranel, P Lahmek, X Causse, et al.
The European Respiratory Journal|August 5, 2017
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater ParisBoris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohortSimon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
The European Respiratory Journal|July 9, 2011
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendationsT Berghmans, F Pasleau, M Paesmans, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2008
Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional studyJean-François Cadranel, Vincent Di Martino, Guy Lambrey, et al.
Pageof 71